| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Revolution Medicines, Inc. (RVMD) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 37 sells. RVMD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 2.34M | $387.81M | - | |
| Other | 278.6K | $46.19M | - | |
| Other | 232.5K | $38.55M | - | |
| COO | 119.9K | $19.88M | - | |
| ? | 96.6K | $16.01M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2020 | Kelsey Stephen Michael46 | See Remarks | Sell | 12,000 | $31.03 | $372,323.78 | -2.3% | |
| Sep 18, 2020 | Goldsmith Mark A52 | See Remarks | Sale+OE | 55,518 | $30.69 | $1,704,113.98 | -18.1% | |
| Sep 10, 2020 | Goldsmith Mark A52 | See Remarks | Sale+OE | 7,043 | $29.02 | $204,418.72 | -2.7% | |
| Sep 10, 2020 | Kelsey Stephen Michael46 | See Remarks | Sale+OE | 4,042 | $29.06 | $117,467.22 | -0.3% | |
| Sep 8, 2020 | Goldsmith Mark A52 | See Remarks | Sale+OE | 1,800 | $29.05 | $52,285.86 | -1.4% | |
| Sep 3, 2020 | Goldsmith Mark A52 | See Remarks | Sale+OE | 3,100 | $29.05 | $90,057.92 | -1.2% | |
| Sep 3, 2020 | Kelsey Stephen Michael46 | See Remarks | Sale+OE | 12,226 | $27.92 | $341,394.72 | -0.6% | |
| Aug 28, 2020 | Kelsey Stephen Michael46 | See Remarks | Sale+OE | 1,732 | $29.01 | $50,247.40 | -0.2% | |
| Aug 27, 2020 | Goldsmith Mark A52 | See Remarks | Sale+OE | 2,539 | $29.01 | $73,652.38 | -1.9% | |
| Aug 13, 2020 | Weber Barbara59 | Director | Sale+OE | 2,000 | $28.00 | $56,000.00 | -35.6% |